Abstract
Objective
Novel treatments are needed to control treatment‐resistant status epilepticus (SE). We present a summary of clinical cases where oral topiramate (TPM) was used in refractory SE (RSE) and superrefractory SE (SRSE).
Methods
A review of medical records was carried out to detect TPM administration in SE patients treated in Frankfurt and Marburg between 2011 and 2016. The primary outcome question concerned SE resolution after TPM initiation.
Results
In total, TPM was used in 106 of 854 patients having a mean age of 67.4 ± 18.1 years, 61 ...
Seguir leyendo →NOV